The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/9093728

Download in:

View as

General Info

PMID
9093728